Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, has announced that one of its equine products – HIPPIRON™ 1000 – has been counterfeited, and was discovered being sold via an Internet website. Regulatory authorities and veterinarian customers have been advised of this situation, along with the elements of the counterfeited product that clearly distinguish it from legitimate HIPPIRON™ 1000.
HIPPIRON™ 1000 from Bioniche fully complies with regulatory standards and is safe for use as recommended. Bioniche sells this injectable iron-sucrose product exclusively to veterinarians and it is the only licensed product of its kind available for veterinary use in Canada.
Any veterinarians or veterinary clients with questions about the integrity of the HIPPIRON™ 1000 in their possession should contact:
Dr. Duncan Hockley
Director, Veterinary Services
Bioniche Animal Health
1-800-265-5464 ext. 1403
[email protected]
“Bioniche is working with the investigating authorities to ensure that no damage results from this counterfeit version of our product,” said Andrew Grant, President of Bioniche Animal Health (Global). “This type of illegal activity cannot be tolerated. Bioniche invests heavily in quality control measures to ensure that only high quality, regulatory compliant products are sold to veterinarians.” Bioniche plans to prosecute any individual involved in the manufacturing, marketing, and/or labelling of counterfeited product.
About HIPPIRON™ 1000
HIPPIRON™ 1000 is an iron-sucrose product for horses that is administered by I.V. injection. It is widely used to treat iron deficiency (equine anaemia). It has been registered with Health Canada and meets all regulatory guidelines for manufacture, testing, and quality assurance. More than one million doses have been administered to horses since the product was launched with no adverse reactions reported. The product is sold exclusively to veterinarians.
For more information, visit www.Bioniche.com
